Sharon L. Turner

Array ( [id] => 1209920 [patent_doc_number] => 06713509 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Controlled release formulation for treating COPD' [patent_app_type] => B1 [patent_app_number] => 09/913997 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6261 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713509.pdf [firstpage_image] =>[orig_patent_app_number] => 09913997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818337 [patent_doc_number] => 20030069295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Use of histamine H3 receptor inverse agonists for the control of appetite and treatment of obesity' [patent_app_type] => new [patent_app_number] => 09/930356 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4439 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069295.pdf [firstpage_image] =>[orig_patent_app_number] => 09930356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828002 [patent_doc_number] => 20020068121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Blends of isoflavones and flavones' [patent_app_type] => new [patent_app_number] => 09/930525 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2598 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068121.pdf [firstpage_image] =>[orig_patent_app_number] => 09930525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344356 [patent_doc_number] => 20020035143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Application of 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) as a promoter blocker of cancer' [patent_app_type] => new [patent_app_number] => 09/925449 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4236 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035143.pdf [firstpage_image] =>[orig_patent_app_number] => 09925449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6864766 [patent_doc_number] => 20030190292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Use of ectone or ectone derivatives for oral care' [patent_app_type] => new [patent_app_number] => 10/363789 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5811 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190292.pdf [firstpage_image] =>[orig_patent_app_number] => 10363789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416882 [patent_doc_number] => 06511986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-28 [patent_title] => 'Method of treating estrogen receptor positive carcinoma' [patent_app_type] => B2 [patent_app_number] => 09/923217 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6256 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511986.pdf [firstpage_image] =>[orig_patent_app_number] => 09923217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033647 [patent_doc_number] => 20020019415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Cancer treatment' [patent_app_type] => new [patent_app_number] => 09/923126 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6842 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019415.pdf [firstpage_image] =>[orig_patent_app_number] => 09923126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873400 [patent_doc_number] => 20020048553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Toothpaste' [patent_app_type] => new [patent_app_number] => 09/917513 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048553.pdf [firstpage_image] =>[orig_patent_app_number] => 09917513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369465 [patent_doc_number] => 06566369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients' [patent_app_type] => B2 [patent_app_number] => 09/908735 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1865 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566369.pdf [firstpage_image] =>[orig_patent_app_number] => 09908735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684030 [patent_doc_number] => 20030119894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells' [patent_app_type] => new [patent_app_number] => 09/910291 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17889 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119894.pdf [firstpage_image] =>[orig_patent_app_number] => 09910291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829212 [patent_doc_number] => 20020068729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Method for treating fibrotic diseases or other indications IC' [patent_app_type] => new [patent_app_number] => 09/905188 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20657 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068729.pdf [firstpage_image] =>[orig_patent_app_number] => 09905188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131619 [patent_doc_number] => 20020077346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Therapeutic compositions for intranasal administration which include ketorolac' [patent_app_type] => new [patent_app_number] => 09/903665 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4695 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077346.pdf [firstpage_image] =>[orig_patent_app_number] => 09903665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6604132 [patent_doc_number] => 20020015718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Use of physiologically compatible sulfinic acids as antioxidant or free-radical scavenger in cosmetic or dermatological preparations' [patent_app_type] => new [patent_app_number] => 09/894619 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5829 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015718.pdf [firstpage_image] =>[orig_patent_app_number] => 09894619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000643 [patent_doc_number] => 20020028808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Use of potassium channel agonists for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/891981 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8765 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028808.pdf [firstpage_image] =>[orig_patent_app_number] => 09891981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495677 [patent_doc_number] => 06403630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Treating cancers associated with overexpression of HER-2/neu' [patent_app_type] => B1 [patent_app_number] => 09/868617 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8345 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403630.pdf [firstpage_image] =>[orig_patent_app_number] => 09868617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225468 [patent_doc_number] => 20020004516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Use of riluzole in the treating acoustic traumas' [patent_app_type] => new [patent_app_number] => 09/882223 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1905 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004516.pdf [firstpage_image] =>[orig_patent_app_number] => 09882223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829335 [patent_doc_number] => 20020068764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'NMDA antagonist' [patent_app_type] => new [patent_app_number] => 09/881178 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9173 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068764.pdf [firstpage_image] =>[orig_patent_app_number] => 09881178 [rel_patent_id] =>[rel_patent_doc_number] =>)